Heparin-induced thrombocytopenia (HIT) is a prothrombotic immune drug reaction caused
by platelet-activating antibodies that in most instances recognize platelet factor 4 …

Introduction: Devastating thromboses can complicate heparin-induced thrombocytopenia
(HIT) and disseminated intravascular coagulation (DIC). In these disorders, acquired …

This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Antithrombotic and Thrombolytic Therapy: American …

Clinical outcomes of 1,478 danaparoid treatment case reports for HIT (involving 1,418
patients) treated between 1982 and mid-2004 are analysed. Treatment in 1,291 episodes …

Background: Heparin-induced anaphylactic and anaphylactoid reactions are of increasing
clinical and scientific interest, particularly given the recent identification of a syndrome of …

This thoroughly updated fifth edition from international experts Warkentin and Greinacher is
the gold standard for accurate diagnosis and management of heparin-induced …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated coagulation side effect of
heparin therapy characterized by thrombocytopenia and by a paradoxical prothrombotic …

Thrombocytopenia and impaired platelet function are known as intrinsic drawbacks of
cardiac surgery and extracorporeal life supports (ECLS). A number of different factors …

Heparin‐induced thrombocytopenia (HIT) is an immune reaction to heparin. It often causes
severe thrombosis which may lead to limb gangrene and thrombosis‐associated death. The …

To review the use of the novel oral anticoagulant (NOAC) agents for the treatment of heparin-
induced thrombocytopenia (HIT) from relevant clinical trial data. A MEDLINE, International …